Research Article
Combination of Enrichment Using Gene Ontology and Transcriptomic Analysis Revealed Contribution of Interferon Signaling to Severity of COVID-19
Table 4
The expression level of healthy control, mild, and severe COVID-19 patients. Note: Values marked with an asterisk are not significantly different
.
| ID GENE | HC mean (N = 5) | MILD mean (N = 5) | SEVERE mean (N = 5) | -value | Gene regulation in patient (up/down-regulated) |
| IFNAR1 | 6.963 ± 0.313 | 8.961 ± 0.282∗ | 9.660 ± 0.305∗ | ≤0.01 | Up | IFI6 | 7.739 ± 0.228 | 10.569 ± 0.739∗ | 10.461 ± 0.505∗ | ≤0.01 | Up | IRF7 | 6.886 ± 0.481 | 5.796 ± 0.102 | 4.985 ± 0.376 | ≤0.01 | Down | IRF3 | 9.699 ± 0.762 | 8.074 ± 0.288∗ | 7.713 ± 0.274∗ | ≤0.01 | Down | IFIT1 | 3.373 ± 0.247 | 5.743 ± 0.565∗ | 5.214 ± 0.752∗ | ≤0.01 | Up | IFIT3 | 2.894 ± 0.286 | 4.387 ± 0.969∗ | 4.699 ± 0.769∗ | ≤0.01 | Up | IFNA6 | 3.140 ± 0.230 | 5.424 ± 0.272∗ | 5.731 ± 1.114∗ | ≤0.01 | Up | IFNB1 | 2.970 ± 1.208∗ | 3.894 ± 0.461∗ | 6.065 ± 0.244 | ≤0.01 | Up | IFNG | 11.731 ± 1.069∗ | 9.729 ± 0.709∗ | 8.273 ± 1.088 | ≤0.01 | Down |
|
|